financetom
Business
financetom
/
Business
/
Healthpeak Properties Boosts Outlook for 2024 Adjusted FFO
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Healthpeak Properties Boosts Outlook for 2024 Adjusted FFO
Nov 19, 2024 6:40 PM

04:46 PM EST, 11/18/2024 (MT Newswires) -- Healthpeak Properties ( DOC ) late Monday nudged its forecast for 2024 adjusted funds from operations slightly higher to reflect the continued strong performance of its portfolio of outpatient medical, laboratory and continuing care retirement communities.

The company is now expecting adjusted FFO this year of $1.57 to $1.59 per share compared with its previous guidance looking for $1.56 to $1.58 per share.

Analysts polled by Capital IQ on average are expecting 2024 AFFO of $1.55 per share.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Casella Waste Systems to Acquire Royal Carting and Welsh Sanitation
Casella Waste Systems to Acquire Royal Carting and Welsh Sanitation
Sep 9, 2024
08:23 AM EDT, 09/09/2024 (MT Newswires) -- Casella Waste Systems ( CWST ) said Monday it has agreed to acquire Royal Carting and Welsh Sanitation and related real estate assets. The transaction is expected to close in Q4. Casella said it would gain access to two solid waste collection operations and two transfer stations in New York from the acquisition....
Tilray Medical Supports Scientific Study on Fibromyalgia With
Tilray Medical Supports Scientific Study on Fibromyalgia With "Positive Outcomes"
Sep 9, 2024
07:57 AM EDT, 09/09/2024 (MT Newswires) -- Tilray Brands ( TLRY ) said a new study examining the real-world impact of cannabinoid treatments on patients with fibromyalgia (FM) has been published in an open-access journal focused on alternative, complementary and integrative medicine. The study, which was supported by Tilray Brands' ( TLRY ) division Tilray Medical, consisted of three patients...
Rezolute Says FDA Removes Partial Clinical Holds on Potential Hypoglycemia Treatment
Rezolute Says FDA Removes Partial Clinical Holds on Potential Hypoglycemia Treatment
Sep 9, 2024
08:20 AM EDT, 09/09/2024 (MT Newswires) -- Rezolute ( RZLT ) said Monday that the US Food and Drug Administration has removed partial clinical holds on ersodetug or RZ358, the biotech firm's drug candidate to treat hypoglycemia caused by congenital hyperinsulinism. The company said it will soon begin startup activities in the US for a global phase 3 study, with...
Northvolt to cut costs, explore strategic partnerships
Northvolt to cut costs, explore strategic partnerships
Sep 9, 2024
STOCKHOLM, Sept 9 (Reuters) - Swedish battery maker Northvolt said on Monday it would cut costs and explore future strategic partnerships while focusing on its large-scale cell manufacturing as the company continues to scale back its rapid expansion. The announcement follows a major review of Northvolt's strategy intended to refocus its business following a series of setbacks such as production...
Copyright 2023-2026 - www.financetom.com All Rights Reserved